Learning that cancer may run in your family can be unsettling. Yet, this knowledge also offers something powerful: the ability to understand your hereditary cancer risk early and to take preventive action for yourself and your loved ones.
Today, advances in genetic cancer screening make it possible to detect inherited mutations, such as those linked to breast, ovarian, or colorectal cancer, long before symptoms appear. A simple DNA analysis provides clear answers and helps define the level of medical monitoring you need, from standard check-ups to personalized surveillance based on your family history.
Whether a mutation is found or not, these results give you a roadmap for staying a step ahead of potential risks.
For those seeking clarity and expert support, Turquie Santé connects patients with top oncogenetics centers in Turkey, offering comprehensive testing, compassionate counseling, and transparent follow-up care.
What is genetic screening?
Genetic screening is a medical test that analyzes your DNA to identify inherited predispositions to cancer. Instead of detecting an existing disease, it highlights genetic mutations that may increase your lifetime risk of developing certain cancers.
It's crucial to understand that this is not a test for cancer itself. Instead, it’s a powerful assessment of your potential risk. Think of it as a strategic map of your genetic landscape, allowing you and your doctors to navigate your future health with foresight, not just hindsight. A positive result doesn't mean you have cancer; it means you have vital information to implement a personalized prevention plan.
There are several forms of genetic cancer screening:
- Targeted gene tests (e.g., BRCA1, BRCA2), widely used for assessing risks of breast and ovarian cancer.
- Multigene panel testing, which examines several cancer-related genes at once for a broader risk evaluation.
- Advanced genomic analysis, capable of detecting rare or less common mutations for an even more detailed understanding of your risk profile.
Genetic screening provides valuable information that can guide proactive decisions and help you stay ahead of potential health concerns.
Which cancers can be detected through genetic screening?
Genetic screening helps identify hereditary forms of cancer, allowing individuals at higher risk to benefit from earlier detection and personalized preventive care. Not all cancers are genetic, but several have well-known mutations that significantly increase risk.
Here are the main cancers that can be assessed through genetic testing:
| Type of cancer | Genes / mutations involved | Why genetic screening helps? |
| Breast & ovarian cancer | BRCA1, BRCA2 | Enables enhanced monitoring, personalized preventive strategies, and earlier detection. |
| Colorectal cancer | Lynch syndrome genes (MLH1, MSH2, MSH6, PMS2, EPCAM) | Allows regular colonoscopies, targeted prevention, and adapted long-term follow-up. |
| Pancreatic cancer | BRCA2, PALB2, CDKN2A | Identifies elevated risk early to establish preventive and surveillance plans. |
| Melanoma / skin cancer | CDKN2A, BRAF | Detects genetic susceptibility and guides specific prevention measures. |
| Thyroid & certain hematological cancers | RET, TP53, and other rare mutations | Supports specialized monitoring, early diagnosis, and referral to expert care. |
Knowing your genetic profile isn’t just about data ; it’s about clarity. It gives you the confidence to anticipate rather than worry, to shape your medical journey with intention, and to make choices that truly align with your long-term health and your family’s well-being.
